HPV legislation in Hawaii
Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :
Incidence & Mortality (2008 Score / 2007 Score)
- Cervical Cancer Incidence Rate: 6.3/100,000 (2 / 1)
- Cervical Cancer Incidence Rate/Race: White: 7.9, Asian/Pacific Islander: 6.3
- Cervical Cancer Mortality Rate: 2.4/100,000 (1 / 1)
- Cervical Cancer Mortality Rate/Race: White: 2.1, Asian/Pacific Islander: 2.5
Screening (2008 Score / 2007 Score)
- Cervical Cancer Screening Rate: 82.0% (1 / 1)
- Cervical Cancer Screening Rate/Race: White: 86.2, Hispanic: 83.2%%, Asian/Pacific Islander: 78.2%
- % Uninsured/Unscreened: 29.1% (1 / 1)
- Medicaid Coverage HPV Testing: Unrestricted (2 / 2)
Healthcare Access (2008 Score / 2007 Score)
- Rate Uninsured Women: 11% (1 / 1)
- % Low Income/Uninsured Women: 22%
Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)
Screening Requirements (0 / 1)
- There are no new screening requirements.
Task Forces (0 / 1)
- There is no new cervical cancer prevention task force legislation.
Access to HPV Vaccines (1 / 1)
- HB 1000 would include the HPV vaccine in the Teen Vax Program for uninsured/underinsured girls age 11–18; carried over to 2008 session.
- HB 590 requires health insurance policies issued in the state to cover the HPV vaccine for people age 11–26; directs Dept. of Health to include HPV vaccine in Teen Vax Program; carried over to 2008 session.
HPV Vaccine Information Programs (0 / 0)
- There is no HPV vaccine information activity.
Miscellaneous (1 / 2)
- SR 137/SCR 213 and HR 160/HCR 202 request the governor to fund breast and cervical cancer screening for low-income women; passed.
- HB 459/SB 1108 would appropriate funding to the Dept. of Health and women’s caucus to conduct an educational program about the causesand prevention of cervical cancer; carried over to 2008 session.
- 2008: Good (13 out of 22 points)
- 2007: Good (11 out of 18 points)
Articles and resources
- Women in Government
- The Marketing of Gardasil in Australia
- The Marketing of Gardasil in Canada
- The Marketing of Gardasil in Europe
- The Marketing of Gardasil in New Zealand
- The Marketing of Gardasil in the United States
- Direct-to-consumer advertising
- Disease Mongering
- Drug industry
- Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.
- "The 'State' of Cervical Cancer Prevention in America - 2008", Women in Government